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ABSTRACT 
In type 2 diabetes patients, endothelin(ET)-receptor-blockade may enhance blood flow 
responses to exercise training. The combination of exercise training and ET-receptor-blockade 
may represent a more potent stimulus to improve vascular function, physical fitness, and 
glucose homeostasis. We assessed the effect of an 8-week exercise training program 
combined with either ET-blockade or placebo on vasculature, fitness and glucose homeostasis 
in people with type 2 diabetes. In a double blind randomized controlled trial, brachial 
endothelium-dependent and –independent dilation (using flow-mediated dilation (FMD) and 
glyceryl trinitrate (GTN), respectively), glucose homeostasis (using HOMA-IR), and physical 
fitness (maximal cycling test) were assessed in 18 men with type 2 diabetes (60±6 years). 
Subjects underwent an 8-week exercise training program with half of the subjects receiving 
ET-receptor-blockade (Bosentan) and the other half a placebo, followed by reassessment of 
the tests above. Exercise training improved physical fitness to a similar extent in both groups, 
but we did not detect changes in glucose homeostasis or vascular function in either group. 
This study suggests no adaptation in brachial and femoral artery endothelial function and 
glucose homeostasis after 8 weeks of training in type 2 diabetes patients. ET-blockade 
combined with exercise training does not additionally alter conduit artery endothelial 
function, physical fitness or glucose homeostasis in type 2 diabetes. 
 
ClinicalTrials.gov identifier: NCT01779609 
KEYWORDS: cardiovascular risk; exercise training; metabolic disease; shear stress; 
bosentan 
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INTRODUCTION 
Type 2 diabetes mellitus is a rapidly growing problem in Western society. Cardiovascular 
disease and vascular complications represent the leading cause of morbidity and mortality in 
type 2 diabetes. Previous studies found an impaired endothelial function in patients with type 
2 diabetes (McVeigh et al., 1992; Clarkson et al., 1996; Williams et al., 1996), which is 
believed to contribute to the pathogenesis of cardiovascular disease in type 2 diabetes patients 
(Beckman et al., 2002; Green et al., 2004). Exercise training represents an effective strategy 
to improve endothelial function in conduit and resistance vessels and, consequently, reduce 
the risk of cardiovascular disease in symptomatic and asymptomatic subjects (see reviews) 
(Green et al.; Thijssen et al.). 
 
Previous studies in animals (Langille & O'Donnell, 1986; Tuttle et al., 2001) and humans 
(Green, 2009) demonstrated that repeated elevation in blood flow, and consequently shear 
stress (Thijssen et al., 2009), is a key stimulus for vessels to adapt in function and structure 
(Tinken et al., 2010). More specifically, recent studies demonstrated that the beneficial effects 
of exercise training on the vasculature largely depend on acute exercise-induced elevations in 
blood flow (Johnson et al.; Zhu et al.; Harris et al., 2007, 2008; Tinken et al., 2010). A 
previous study found that type 2 diabetes patients show an attenuated blood flow response to 
exercise compared to healthy controls (Lalande et al., 2008). This diminished blood flow and 
shear stress response to exercise may prevent an optimal stimulus for adaptation of the 
vasculature in type 2 diabetes (Bauer TA, 2007; Lalande et al., 2008), and may even 
contribute to microvascular complications (Womack et al., 2009). Therefore, exercise training 
combined with pharmacological up- or downregulation of vasoactive substances may 
potentially lead to superior effects on the vasculature than exercise training alone (Buford et 
al.). 
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We recently demonstrated that systemic ET-1 blockade leads to an increased exercise-induced 
blood flow response during handgrip exercise in type 2 diabetes, but not in healthy controls 
(Schreuder et al., 2014). Accordingly, exercise training combined with an ET-antagonist in 
type 2 diabetes patients may enhance the blood flow response and thereby the impact of 
exercise training on the vasculature and physical fitness. An increased blood flow has been 
demonstrated to represent a stimulus to upregulate glucose homeostasis, possibly via 
potentiation of insulin-driven capillary recruitment (Rattigan et al., 2001; Clark et al., 2003; 
De Filippis et al., 2006; Lteif et al., 2007). Therefore, the purpose of this study was to 
perform a randomised controlled trial (RCT) to assess the effect of an 8-week exercise-
training program with either ET-blockade or a placebo on the vasculature, fitness and glucose 
homeostasis in patients with type 2 diabetes. 
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METHODS 
Subjects 
18 men (60±6 years) who were diagnosed with type 2 diabetes for at least two years were 
recruited from the general population through advertisements for our double blind 
randomized controlled trial (RCT; ClinicalTrials.gov identifier: NCT01779609). Exclusion 
criteria included overt cardiovascular disease, smoking, type I diabetes mellitus, age <40 or 
>65, diabetes-related manifest vascular complications, increased levels of liver 
aminotransferases (ASAT >120 U/L ALAT >135 U/L), glibenclamide use, use of calcineurin 
inhibitors, use of HIV-drugs due to a possible interference with Bosentan, and use of drugs 
that interfere with CYP3A4, CYP2C9, CYP3A4 and/or CYP2C9. The study procedures were 
approved by the medical ethical committee of the Radboud University Nijmegen Medical 
Centre and adhered to the Declaration of Helsinki. All subjects gave written informed consent 
before participation in this study. During this study, no adverse events occurred in the study 
population. 
 
Experimental design 
Patients reported to the laboratory for initial assessment of brachial artery function and 
structure, glucose homeostasis, and physical fitness. Subsequently, all subjects underwent an 
8-week exercise-training program. In a randomized, double-blind manner, subjects combined 
exercise training with either a dual ET-blocker (EX+ET-blocker) or a placebo (EX+placebo) 
for 8 weeks. Ingestion of the dual ET-blocker (Tracleer, Actelion Pharmaceuticals) during the 
first 4 weeks represented 62.5 mg twice per day, followed by four weeks of 125 mg twice 
daily. This dosage has been used in previous studies and has proven to be effective and well 
tolerated (Monfredi et al., 2011). The other group used a placebo that had the same size, 
weight, taste, and colour as the dual ET-blocker and was also taken twice daily. Subjects and 
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researchers were blinded for the ingestion of placebo or the ET-blocker. Randomization was 
executed by the Radboud University Nijmegen Medical Centre pharmacy, who provided 
sequentially numbered containers. Immediately after the 8-week intervention, within seven 
days of the last exercise bout, we repeated all tests as listed above. 
 
Measurements: physical fitness and subject characteristics 
Subject characteristics. During a screening procedure at the first visit all subjects completed a 
questionnaire concerning their medical history and medication use. We measured height, 
weight, resting blood pressure after a 5-minute seated rest using a manual 
sphygmomanometer. A venous blood sample was taken for assessment of fasting glucose, 
insulin, total cholesterol, HDL, LDL, triglycerides, ASAT and ALAT. From the glucose and 
insulin levels we calculated the HOMA-IR index as a valid measure of insulin resistance 
(Matthews et al., 1985). 
Physical fitness. On a subsequent day, subjects performed an incremental cycle exercise test 
to examine maximal workload and peak oxygen consumption. Also, data from this test were 
used to determine maximal heart rate, which was used to calculate work-load during exercise 
training. Each subject performed an incremental maximal exercise test on a cycling ergometer 
(Lode, Excalibur, Groningen, the Netherlands) before and after the training program. These 
tests started at a power output of 10 W for 1 min and power output increased by 10 W/min 
until exhaustion. Subjects were instructed to maintain a cadence of between 60 and 80 rpm 
during the test. We continuously recorded oxygen consumption (VO2, in ml O2/kg per min), 
ventilation (Ve, in l/min), respiratory quotient (RQ) (Oxycon IV, Jaeger, Germany) and heart 
rate (HR, in bpm). Furthermore, we measured blood lactate levels (mmol/l) using Accutrend® 
Lactate (Roche Diagnostics GmbH, type 3012522, Mannheim, Germany) before and 2 min 
after finishing the maximal exercise test. 
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Measurements: vascular function 
All subjects refrained from alcohol, caffeine, and vigorous physical exercise for at least 24 
hours prior to testing, and were fasted for at least 6 hours. All tests were performed in 
laboratory conditions with constant temperature (20°C) and humidity (35%). We performed 
all tests between 8 AM and 4 PM, but to control for variation in FMD pre- and post exercise 
training measurements for each subject were performed at the same time of day to prevent 
diurnal variation in the FMD response (Jones et al.). 
 
Brachial artery endothelium-dependent dilation. Measurement of brachial artery 
endothelium-dependent dilation (using flow-mediated dilation (FMD)) was performed by an 
experienced vascular sonographer. A 10 MHz multifrequency linear array probe attached to a 
high resolution ultrasound machine (T3000; Terason, Burlington, MA, USA) was used to 
image the brachial artery in the distal one-third of the upper arm. When an optimal image was 
obtained, the probe was held stable and the ultrasound parameters were set to optimize the 
longitudinal, B-mode images of lumen–arterial wall interface. 
For assessment of the pre-exercise FMD, subjects rested in the supine position for a period of 
at least 15 minutes to facilitate baseline assessment of artery diameter and blood flow. To 
examine brachial artery FMD, the arm was extended and positioned at an angle of ∼80 
degrees from the torso. A rapid inflation and deflation pneumatic cuff was positioned on the 
forearm of the imaged arm immediately distal to the olecranon process to provide a stimulus 
of forearm ischaemia.  Continuous Doppler velocity assessment was obtained using the 
lowest possible insonation angle (always <60 degrees), which did not vary during each 
measurement. The forearm cuff was inflated to 220 mmHg for 5 min. Diameter and flow 
recordings resumed 30 s prior to cuff deflation and continued for 3 min thereafter. Assessment 
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of brachial artery FMD was repeated after the exercise bout and started within 2 min of 
cessation of exercise. Time to peak was calculated from the point of cuff deflation to the 
maximum postdeflation diameter. Calculation of FMD and time to peak were therefore 
observer-independent and based on standardized algorithms applied to data, which had 
undergone automated edge-detection and wall-tracking. 
Brachial artery endothelium-independent dilation. Following a rest period of at least 15 
minutes to allow brachial artery diameter and flow to return to baseline levels, a 1-min 
baseline recording of diameter and flow was taken. Subsequently, brachial artery endothelium-
independent vasodilation was examined after administration of a single spray of sublingual 
GTN (400 µg), an NO donor. This was followed by 10 min continuous recording of brachial 
artery diameter and blood flow. 
Brachial artery peak blood flow. After a >15-min rest period, a 1 min baseline recording of 
brachial artery diameter and blood flow was performed. Next, brachial artery dilation was 
examined after a 5-min period of ischemia, consisting of 1 min ischemia, followed by 3-min 
isotonic handgrip exercise and a final 1 min of ischemia. Handgrip exercise involved 1 
contraction every 2 s of a 3-kg load. Peak blood flow was defined as the blood flow area 
under the curve of the highest 10s window after cuff deflation. The peak hyperemic forearm 
blood flow in response to this stimulus in humans provides a valid and accepted index of 
resistance artery size or remodeling (Naylor et al., 2005). We resumed diameter and flow 
recordings 30 s prior to cuff deflation and continued for 3 min thereafter. 
Superficial femoral artery endothelium-dependent dilation. After measurement of the brachial 
artery, we continued with measurements of the superficial femoral artery. The Terason 
ultrasound equipment was used to measure femoral artery diameter and flow. The cuff was 
placed at the thigh of the imaged leg, directly above the knee. Measurement of superficial 
femoral artery endothelium-dependent function was performed as described above for the 
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brachial artery. Measurements continued for 5 minutes after cuff deflation. A previous study 
found that this procedure results in a largely NO-mediated, endothelium-dependent dilation of 
the superficial femoral artery (Thijssen et al.). 
 
Exercise training 
Exercise training was performed over an 8-week training period with subjects visiting our 
facility 3 times a week. Each exercise session was supervised by a well-trained researcher and 
consisted of a 5-minute warming-up, followed by a circuit of resistance exercises (leg press, 
calf raise, leg curl, leg extension, lower back, abdominal crunch, 3 series of 12 repetitions 
each, with 1 minute of rest between sets within each exercise) interspersed with aerobic 
activities (e.g. cycling, running) (Maiorana et al., 2002; Watts et al., 2004). The total protocol 
was as follows: 5 minutes warming-up (cycling), 5 minutes of cycling, leg curl, leg extension, 
5 minutes of running, lower back, abdominal crunch, 5 minutes of cycling, leg press, calf 
raise, 5 minutes of running. The total duration of a training session was approximately 60 
minutes. A heart rate monitor (Polar Electro Oy, Kempele, Finland) was used to continuously 
monitor heart rate during the aerobic exercise and heart rate was maintained at 70-75% of 
heart rate reserve. The intensity level for each of the resistance exercises was set at a level 
which enables the participant to complete the three series of 12 repetitions. Intensity was 
increased each week under the guidance of the trainers. If a participant missed a supervised 
exercise session, an extra session was planned in the same or following week, so that each 
participant performed a total of 24 supervised sessions (100% compliance). 
 
Data Analysis 
Post-test analysis of brachial artery diameter and velocity was performed using custom-
designed edge-detection and wall-tracking software, which is independent of investigator bias 
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(Woodman et al., 2001). Briefly, the echo-Doppler signal was real-time encoded and stored as 
a digital file. Subsequent software analysis of these data was performed at 30 Hz using an 
icon-based graphic programming language and toolkit (LabView 6.02; National Instruments, 
Austin, TX). The program allows users to identify a region of interest on the clearest portion 
of the vascular wall. It then identifies, via the intensity of the brightness of the walls versus 
the lumen of the vessel, the walls of the artery. B-mode image were viewed, and regions of 
interest were selected for diameter and blood velocity. From this synchronized diameter and 
velocity data, blood flow (the product of lumen cross-sectional area and Doppler velocity) 
was calculated at 30 Hz. Baseline diameter, flow, and shear rate were calculated as the mean 
of data acquired across the 1 minute preceding the cuff inflation period. 
FMD was calculated using the baseline and peak diameter following cuff deflation. Peak 
diameter was automatically detected according to an algorithm, which identified the 
maximum bracket of data subsequent to performance of a moving window smoothing 
function. This smoothing routine calculates the median value from 100 consecutive samples, 
before the window shifts to the next bracket of data, which shares 20% overlap with the 
preceding bracket. The maximum value of all the calculated median values is then 
automatically detected and chosen to represent the peak of the post-deflation artery diameter 
curve. FMD was calculated as the percentage rise of this peak diameter from the preceding 
baseline diameter. We have shown that reproducibility of diameter measurements using this 
semi-automated software is significantly better than manual methods, reduces observer error 
significantly, and possesses an intra-observer coefficient of variance of 6.7% (Woodman et 
al., 2001). Analysis of the conduit artery dilator capacity and glyceryl trinitrate measurements 
was performed using the same methods. Shear rate is represented as shear rate area-under-the-
curve between the moment the cuff is released and the end of the FMD measurement (3 min 
for brachial, 5 min for superficial femoral artery). 
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Statistical analysis 
Statistical analyses were performed using SPSS 20.0 (SPSS, Chicago (Illinois), USA) 
software. According to Woodman et al. our sample size is sufficient to detect clinically 
relevant differences in our primary outcome measures (Woodman et al., 2001). All data are 
reported as mean (SD) unless stated otherwise, and statistical significance was set a priori at 
P≤0.05. Unpaired Student’s t-tests were used to compare baseline values between groups. A 
two-way repeated measures ANOVA was used to examine changes in physical fitness, glucose 
homeostasis and vascular function/structure across the exercise-training period (‘training’; 0 
versus 8 weeks), and whether the magnitude of exercise training mediated adaptations differ 
between groups (‘group’; EX+ET-blockade versus EX+placebo). When a significant main- or 
interaction-effect was found, post-hoc comparisons were performed to identify differences 
with/without ET-receptor blockade. Post-hoc analysis was performed using the least 
significant difference (LSD) method for pair-wise multiple comparisons when a significant 
main effect was observed (Perneger, 1998). According to a recent study by Atkinson et al., 
inadequate scaling for FMD would be present if the upper confidence limit of the regression 
slope of the relationship between logarithmically transformed base diameter and peak 
diameter is less than one (Atkinson et al., 2013). In such an event, FMD% is not an 
appropriate measure to estimate endothelial function. We checked our data for this 
phenomenon, and where appropriate we performed the allometric modelling solution 
proposed by Atkinson et al.(Atkinson et al., 2013). 
 
RESULTS  
Baseline characteristics 
Prior to the 8-week intervention, we found no significant differences between EX+ET-
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blockade (N=8) and EX+placebo (N=10) for height, weight, BMI, blood pressure, total 
cholesterol, lipid profile, and plasma-Endothelin-1 (all comparisons P>0.05, Table 1). The 8-
week exercise training intervention did not alter these parameters in EX+ET-blockade nor in 
EX+placebo, except for a significant decrease in triglycerides in both groups (Table 1). 
 
Physical fitness 
Prior to the intervention, we found significantly lower maximal workload in EX+ET-blockade 
compared to EX+placebo, but no differences in maximal oxygen uptake (Table 2). Exercise 
training resulted in a significant increase in maximal oxygen uptake and maximal load, which 
was comparable between both groups (Table 2). For both groups, maximal heart rate and peak 
lactate were similar before and after the exercise training program (Table 2). 
 
Glucose homeostasis 
Before training, we found no differences in insulin, glucose and HOMA-IR between EX+ET-
blockade and EX+placebo groups (all comparisons P>0.05, Table 3). In both groups, we 
found no main or training*group-interaction effect on blood glucose and insulin levels, and 
insulin resistance (HOMA-IR) (Table 3). 
 
Vascular function 
At baseline, we found no differences between groups in brachial artery FMD, peak diameter, 
peak blood flow and GTN or superficial femoral artery FMD (all comparison P>0.05, Table 
4). 
Brachial artery endothelium-dependent dilation. Exercise training with or without ET-
receptor blockade did not change brachial artery flow mediated dilation, baseline diameter or 
shear rate area-under-the-curve (Table 4). We found a significant training*group interaction 
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for shear rate area-under-the-curve (P=0.009, table 4). Post-hoc testing revealed that the 
exercise training program significantly decreased shear rate area-under-the-curve in the 
EX+ET-blockade group (P=0.006), but not in the EX+placebo group (P=0.363). 
Brachial artery endothelium-independent dilation. Endothelium-independent vascular 
function, measured as the dilatory response to a single sublingual dose of glyceryl trinitrate 
(GTN), was not influenced by exercise training with or without ET-receptor blockade (Table 
4). We also found no impact of exercise training and/or ET-blockade on FMD/GTN-ratio 
(Table 4). 
Brachial artery peak blood flow. We found a significant training*group interaction for the 
impact of the 8-week intervention on brachial artery peak blood flow. Post-hoc testing 
revealed that the exercise training program significantly increased peak blood flow in the 
EX+ET-blockade group (P=0.050), but not in the EX+placebo group (P=0.086) (Table 4). 
Superficial femoral artery endothelium-dependent dilation. In the superficial femoral artery, 
exercise training with or without ET-receptor blockade did not change flow mediated dilation, 
baseline diameter or shear rate area-under-the-curve (Table 4). 
 
DISCUSSION 
As a logical follow-up of a recent study where we found ET-blockade to enhance exercise-
induced blood flow in type 2 diabetes (Schreuder et al., 2014), the purpose of this study was 
to perform a randomised controlled trial (RCT) to assess the effect of an 8-week exercise-
training program combined with ET-blockade. First, we confirmed the potent effect of 
exercise training given the significantly improved peak oxygen uptake (P=0.006) and peak 
workload (P=0.001). In contrast to our hypothesis, we found no effect of exercise training on 
glucose homeostasis or vascular function in the upper or lower limbs. More importantly, we 
found that ET-blockade did not have any superior effects on the impact of exercise training on 
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our primary outcome parameters. This suggests that ET-blockade, despite the acute effects on 
blood flow, does not potentiate the effect of exercise training on the vasculature, fitness and 
glucose homeostasis in type 2 diabetes. 
 
Exercise training significantly increased peak oxygen consumption with 12%, indicating that 
our training intervention was successful in improving physical fitness levels. The increase in 
peak oxygen consumption relates to training itself, since we did not find any differences in 
peak heart rate and lactate between both incremental cycling tests. Despite these training 
effects, we found no effect of our 8-week intervention on glucose homeostasis. Several other 
studies that investigated the effect of an 8-26 weeks training exercise program have found that 
exercise training improves glucose homeostasis (Boule et al., 2001; Maiorana et al., 2002; 
Snowling & Hopkins, 2006), whereas other studies with similar duration and intensity do not 
confirm this finding (Kaplan et al., 1987; Lehmann et al., 1995; Tessier et al., 2000). A 
potential explanation for this disparity in the literature is that glucose homeostasis in older 
type 2 diabetes patients (>55 years) is less likely to improve during exercise training 
compared to younger subjects (Zierath & Wallberg-Henriksson, 1992). An alternative 
explanation is that a priori levels of glucose influence the ability of exercise training to 
improve glucose homeostasis. Indeed, Maiorana et al. found an improvement in fasting 
glucose from 12.0±0.5 to 9.8±0.5 mmol/L (Maiorana et al., 2002), which both represent 
relatively high resting levels of glucose. In contrast, we found pre-training fasting glucose 
levels that were well below the post-training values reported by Maiorana et al. When 
comparing responders (n=6) and non-responders (n=12) in our study regarding the impact of 
exercise training on glucose levels, we did not find differences between groups for baseline 
characteristics or medication use. Therefore, it is unlikely that differences in baseline 
characteristics or medication use influenced our outcome parameters. 
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In the present study, we did not find any effect of adding ET-blockade to exercise training on 
circulating resting insulin or insulin sensitivity. Animal studies have suggested that ET-1 
stimulates insulin release in pancreatic islets (Gregersen et al., 1996; De Carlo et al., 2000; 
Lai et al., 2007). However, ET-1 has also been shown to reduce pancreatic blood flow 
(Takaori et al., 1992; Liu et al., 1995), which could interfere with normal pancreatic function. 
ETA-blockade may reverse this decreased flow, but literature is not unequivocal on this point 
(Foitzik et al., 1998; Lai et al., 2007). Nonetheless, in our study we observed no impact of 8 
weeks Bosentan ingestion on insulin levels or insulin resistance. 
  
We found no effect of exercise training on flow-mediated dilation in the brachial or superficial 
femoral artery. Given the number of subjects (total n=18), the fact that both arteries show 
similar responses, the double-blind nature of our study (including the analysis), and the small 
coefficient of variance that is achieved by our FMD-technique, we believe it is unlikely that 
measurement or methodological errors explain our effect. A potential explanation for our 
findings may relate to a time-course in vascular adaptations during exercise training in type 2 
diabetes. A previous study found that changes in flow mediated dilation occur in the first two 
weeks of exercise, followed by a normalisation when exercise was continued in healthy men 
(Tinken et al., 2008). If subjects in our study demonstrate a similar time-course, the post-
exercise FMD after 8 weeks of training missed any adaptation that occurred in the FMD in 
response to exercise training. However, no previous study examined the potential presence of 
a time-course in adaptation in FMD in response to exercise training in subjects with 
cardiovascular risk or disease, who typically demonstrate a priori endothelial dysfunction. 
Alternatively, it is possible that exercise training in subjects with a priori endothelial 
dysfunction takes longer than normal to induce significant improvements in endothelial 
function. Either way, future studies should perform multiple assessments of FMD to examine 
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the time-course and/or adopt a longer exercise training duration. 
 
Although changes in endothelial function after exercise training are frequently reported 
(Maiorana et al., 2001; Colberg et al., 2002), not all studies have consistently found this effect 
in type 2 diabetes (Colberg et al., 2005; Sonne et al., 2007). One explanation for the 
conflicting results relates to the baseline FMD, with a higher pre-training FMD allowing for 
less adaptation after exercise training. For instance, Maiorana et al found a significant 
increase in brachial artery FMD from 1.7±0.5% to 5.0±0.4%, where in our study, the mean 
baseline FMD in the EX+ET-blockade and EX+placebo groups was 4.3±1.2 and 3.6±2.3, 
respectively. An alternative explanation for our unexpected observation of a preserved FMD 
response after training is that shear rate during the FMD measurement was significantly lower 
in the EX+ET-blockade group. As shear is the main stimulus for flow mediated dilation 
(Thijssen et al.), this finding may indicate that the sensitivity of the endothelium was 
increased in the EX+ET-blockade group.  
 
Previous studies in animals (Langille et al., 1989) and humans (Green et al.; Tinken et al., 
2010; Naylor et al., 2011; Birk et al., 2012) have demonstrated that repeated increases in 
shear rate represent a key stimulus for vascular adaptation. In an earlier study we have shown 
that Bosentan acutely increases exercise-induced blood flow, but not shear rate. This may 
explain why ET-blockade did not result in a superior effect on changing endothelial function 
in the present study. 
 
Limitations. Strong points of our study include a randomised, double-blind design, the use of 
semi-automated software, and the use of a highly controlled exercise protocol. Some 
limitations need to be addressed. First, we used a dual ET-1 blocker. Previous studies have 
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demonstrated that type 2 diabetes is specifically associated with an upregulation of the ETA-, 
but not ETB-receptors. Even though in a previous study we have successfully increased 
exercise-induced blood flow during a single bout of exercise using a dual ET-1 blocker 
(Schreuder et al., 2014), larger effects may be achieved with selective ETA-receptor blockade 
(Sachidanandam et al., 2008; Settergren et al., 2008). A second limitation is that our main 
comparison was between, as opposed to within subjects. A randomised cross-over design, 
with a sufficient ‘wash-out and detraining’ period between training periods would yield 
smaller variations and possibly larger effects. However, a major concern would be that 
subjects are truly untrained at baseline, and any feasible detraining period would not be 
comparable to the inactive period prior to the start of the study. Therefore, we believe that our 
set-up utilising between-subjects comparisons is the best practical option. Finally, we have 
powered our sample size to detect changes in endothelial function. Therefore, our sample size 
may be too small to detect changes in insulin and glucose levels, potentially explaining why 
we did not find an effect of training or Bosentan on glucose homeostasis. 
 
In conclusion, 8 weeks of exercise training significantly improved physical fitness in patients 
with type 2 diabetes mellitus, but we did not detect any effect on glucose homeostasis or 
brachial and femoral artery endothelial function. Furthermore, in contrast to our hypothesis, 
ET-blockade had no additional effect on our primary outcome parameters. This suggests that 
ET-blockade does not potentiate the effect of exercise training on conduit artery endothelial 
function, fitness and glucose homeostasis in type 2 diabetes. 
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Table 1. Body characteristics in patients with type 2 diabetes mellitus that used bosentan (EX+ET), and patients with type 2 diabetes mellitus that used 
placebo (EX+placebo). Data is presented as mean ± SD. P-values represent a two-way repeated measures ANOVA. 
 
EX+ET-blockade 
N=8 
EX+placebo 
N=10 
2-way ANOVA 
Parameter Pre Post Pre Post Training Group Training*Group 
Age (yrs) 60±5  59±6   0.611  
Height (cm) 174±8  178±4   0.185  
Weight (kg) 99.5±23.9 98.1±22.8 101.5±16.3 102.1±17.1 0.582 0.750 0.177 
Body mass index (kg/m2) 32.8±8.3 32.4±8.2 31.9±4.6 32.1±4.9 0.644 0.843 0.199 
Systolic blood pressure (mmHg) 136±10 132±11 138±17 135±12 0.227 0.841 0.641 
Diastolic blood pressure (mmHg) 83±9 78±5 86±11 83±8 0.079 0.727 0.239 
Cholesterol (mmol/L) 4.7±0.9 4.4±0.7 4.0±1.1 3.8±0.9 0.133 0.138 0.815 
High-density lipoprotein (mmol/L) 1.0±0.5 1.0±0.3 1.0±0.2 1.0±0.2 0.480 0.926 0.808 
Low-density lipoprotein (mmol/L) 2.9±0.6 2.8±0.6 2.2±1.1 2.2±1.1 0.561 0.172 0.998 
Triglycerids (mmol/L) 1.8±0.6 1.4±0.5 1.6±0.9 1.4±1.0 0.011 0.790 0.395 
ET-1 (pg/mL) 1.0±0.6 0.9±0.6 0.5±0.4 0.7±0.6 0.856 0.095 0.247 
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Table 2. Outcome parameters pre and post 8-weeks of exercise training in patients with type 2 diabetes mellitus with either ET-blockade (EX+ET) or placebo 
(EX+placebo). Data is presented as mean ± SD. P-values represent a two-way repeated measures ANOVA. 
 
 
EX+ET-blockade 
(N=8) 
EX+placebo 
(N=10) 
2-way ANOVA 
Parameter Pre Post Pre Post Training Group Training*Group 
Peak Oxygen Uptake (mLO2/min/kg) 20.7±1.6 23.8±4.2* 23.3±6.4 25.6±6.0* 0.006 0.339 0.619 
Peak workload (Watt) 137±29 173±40* 171±34# 205±34* 0.001 0.048 0.834 
Maximal Heart Rate (1/min) 159±11 159±10 156±12 159±12 0.467 0.788 0.371 
Peak lactate (mmol/L) 7.1±3.8 8.6±1.0 8.4±2.0 9.8±2.7 0.284 0.447 0.932 
*Post-hoc significantly different from Pre at P≤0.05, #Significantly different between groups at baseline at P≤0.05 
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Table 3. Glucose homeostasis outcome parameters pre and post an 8-week training intervention in patients with type 2 diabetes mellitus with either ET-
blockade  (EX+ET) or placebo (EX-placebo). Data is presented as mean ± SD. P-values represent a two-way repeated measures ANOVA. 
 
EX+ET-blockade 
(N=8) 
EX+placebo 
(N=10) 
2-way ANOVA 
Parameter Pre Post Pre Post Training Group Training*Group 
Glucose (mmol/L) 6.7±1.1 6.9±0.5 7.6±2.5 6.4±1.5 0.454 0.696 0.239 
Insulin (mU/L) 10.8±5.3 11.0±4.4 15.4±9.4 17.0±13.0 0.582 0.214 0.666 
HOMA-IR (10/%S) 3.2±1.4 3.4±1.5 5.4±3.8 5.1±4.5 0.990 0.176 0.700 
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Table 4. Vascular outcome parameters pre and post 8-weeks of exercise training in patients with type 2 diabetes mellitus with either ET-blockade (EX+ET) or 
placebo (EX-placebo). Data is presented as mean ± SD. P-values represent a two-way repeated measures ANOVA. 
 
EX+ET-blockade 
(N=8) 
EX+placebo 
(N=10) 
2-way ANOVA 
Brachial artery Pre Post Pre Post Training Group Training*Group 
Diameter (mm) 4.3±0.6 4.4±0.6 4.7±0.6 4.5±0.6 0.667 0.366 0.316 
Flow Mediated Dilation (FMD, %) 4.3±1.2 4.8±2.5 3.6±2.3 4.1±1.8 0.335 0.413 0.982 
Shear RateAUC (s, 103) 22.6±8.9 15.5±7.0* 14.7±6.6 17.0±6.5 0.151 0.305 0.009 
Glyceryl Trinitrate (GTN, %) 17.8±7.8 14.1±4.8 14.8±5.8 12.3±7.1 0.119 0.336 0.742 
FMD/GTN 0.30±0.17 0.37±0.23 0.27±0.16 0.48±0.36 0.110 0.679 0.392 
Peak blood flowAUC (mL/min) 603±246 854±293* 980±462 787±294 0.701 0.299 0.008 
 
Superficial femoral artery 
Diameter (mm) 
 
 
7.6±1.4 
 
 
7.3±1.5 
 
 
7.3±0.7 
 
 
7.2±0.8 
 
 
0.356 
 
 
0.727 
 
 
0.390 
FMD (%) 3.1±0.9 3.1±1.9 3.2±1.3 3.1±1.5 0.960 0.910 0.841 
Shear RateAUC (s, 103) 4.2±2.7 5.3±4.5 4.8±3.8 7.0±5.2 0.160 0.523 0.641 
*Post-hoc significantly different from Pre at P≤0.05 
